PharmaEngine, Inc. (4162) Stock Price & Analysis
4162 Stock Chart & Stats
- Day’s Range
- TWD 49.50 - TWD 53.60
- 52-Week Range
- TWD 49.50 - TWD 74.40
- Previous Close
- TWD 54.60
- Volume
- N/A
- Average Volume (3M)
- 232.14K
- Market Cap
- TWD 7.44B
- Enterprise Value
- TWD 3.73B
- Total Cash (Recent Filing)
- TWD 5.07B
- Total Debt (Recent Filing)
- TWD 37.78M
- Price to Earnings (P/E)
- 14.2
- Beta
- 0.42
- Next Earnings
- Nov 11, 2026 (Est.)
- EPS Estimate
- 0.96
- Last Dividend Ex-Date
- Aug 17, 2026
- Dividend Yield
- 3.78%
4162 FAQ
What was PharmaEngine, Inc.’s price range in the past 12 months?
What is PharmaEngine, Inc.’s market cap?
When is PharmaEngine, Inc.’s upcoming earnings report date?
How were PharmaEngine, Inc.’s earnings last quarter?
Is PharmaEngine, Inc. overvalued?
Does PharmaEngine, Inc. pay dividends?
What is PharmaEngine, Inc.’s EPS estimate?
How many shares outstanding does PharmaEngine, Inc. have?
What happened to PharmaEngine, Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of PharmaEngine, Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
PharmaEngine, Inc.
PharmaEngine, Inc. is a biopharmaceutical firm specializing in the creation and advancement of oncology therapeutics, primarily targeting markets in Taiwan and Europe. Its leading drug candidate is ONIVYDE, an innovative liposomal formulation of irinotecan. This topoisomerase 1 inhibitor is designed to treat metastatic pancreatic cancer. The company's pipeline also includes PEP06, currently in Phase I clinical trials for various cancers, and PEP07. PEP07, a Chk1 inhibitor in preclinical development, is being investigated for its ability to induce DNA damage and programmed cell death (apoptosis), leading to "replication catastrophe" in cancer cells. Established in 2002, PharmaEngine, Inc. maintains its corporate headquarters in Taipei, Taiwan.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Hong-Ren Wang
- Employees
- 45
- Website
- www.pharmaengine.com
- Address
- 10 Minsheng East Road, Taipei, TP, 104, TW
PharmaEngine, Inc. (4162) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |

